• Thu, January 3, 2019
  • Wed, January 2, 2019

David Amsellem Upgraded (BHC) to Buy on, Jan 2nd, 2019

David Amsellem of Piper Sandler, Upgraded "Bausch Health Companies Inc." (BHC) to Buy on, Jan 2nd, 2019.

David has made no other calls on BHC in the last 4 months.



There are 3 other peers that have a rating on BHC. Out of the 3 peers that are also analyzing BHC, 1 agrees with David's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Douglas Miehm of "RBC Capital" Maintained at Hold with Increased Target to $30 on, Monday, October 8th, 2018


These are the ratings of the 2 analyists that currently disagree with David


  • Raghuram Selvaraju of "HC Wainwright & Co." Upgraded from Hold to Strong Buy and Increased Target to $58 on, Friday, December 14th, 2018
  • David Risinger of "Morgan Stanley" Upgraded from Hold to Buy on, Monday, November 5th, 2018